- Jupiter Bioscience in negotiation for Rs 75 cr contract; stock up
Shares of Jupiter Bioscience moved higher after the company announced that it is in negotiation with European multinational pharmaceutical ...
27 Dec, 2010, 10.23 AM IST
- Peptide is an emerging field in pharma: Venkat R Kalavakolanu, CMD, Jupiter Bioscience
In a chat with ET Now, Venkat R Kalavakolanu, CMD, Jupiter Bioscience, talks about the peptide business.
08 Oct, 2010, 12.32 PM IST
- Looking for targets of 115-120 in Jupiter Biosciences: Devang Visaria, devangvisaria.com
Devang Visaria, Chief Strategist, devangvisaria.com, in a chat with ET Now talks about his stock ideas.
09 Aug, 2010, 04.25 PM IST
- Ranbaxy in talks to acquire Bangalore vaccine co for Rs 50-cr
Ranbaxy Laboratories has started discussions to buy a privately-held Bangalore-based vaccine company, two persons familiar with the develop...
07 Jan, 2010, 01.18 AM IST
- Investor ire over share pledging hits Jupiter Bio, Assam Co, Videocon
Upset over promoters pledging shares in their company, investors were selling Jupiter Bioscience, Assam Company and Videocon Industries in ...
17 Feb, 2009, 12.04 PM IST
- Fate of Ranbaxy-Jupiter deal hangs in balance
Pharma major Ranbaxy Laboratories has missed the deadline for conversion of equity warrants issued by Jupiter Bioscience.
16 Jan, 2009, 02.03 AM IST
- Global meltdown raises joint venture opportunities in biotech
The global meltdown may lead to more joint ventures and acquisitions among the foreign and domestic biotech companies in the current fiscal...
02 Nov, 2008, 06.31 PM IST
- Daiichi buys promoter stake in Ranbaxy at Rs 737 per share
Japanese drugmaker Daiichi Sankyo has bought entire 35 per cent promoters stake in Ranbaxy Laboratories at Rs 737 per share.
11 Jun, 2008, 12.39 PM IST
- Indian drug cos prepare a peptide mix
As blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...
14 Jun, 2007, 01.49 AM IST
- Ranbaxy picks up 14.9% stake in Jupiter
Ranbaxy Laboratories has acquired 14.9% stake in Hyderabad-based specialised compound maker Jupiter Bioscience for Rs 46 crore.
30 May, 2007, 03.01 AM IST
- Ranbaxy buys 15 pc stake in Jupiter Bio
Ranbaxy acquired the stake in Jupiter Bioscience as part of its product portfolio expansion.
29 May, 2007, 11.20 AM IST
- Jupiter Bio to issue 32 lakh warrants to Ranbaxy
Jupiter Bioscience, a manufacturer of specialised organic compounds, on Tuesday said it will issue up to 31.77 lakh equity share warrants t...
15 May, 2007, 04.20 PM IST
- Jupiter Bio ropes in Dubai FIs to fund expansion
Two Dubai-based financial institutions are set to invest $15 million in Hyderabad-based specialised organic compound manufacturer Jupiter B...
26 Apr, 2007, 02.15 AM IST
- Jupiter gets nod for stake sale to Ranbaxy
In a filing to BSE, Jupiter Bioscience said its board of directors have ratified the term sheet.
13 Apr, 2007, 03.48 PM IST
- Ranbaxy, Jupiter Bioscience enter into marketing tie-up
Ranbaxy Laboratories is about to enter into a 10-year co-marketing agreement with Jupiter Bioscience to tap the $6-billion global peptide p...
10 Apr, 2007, 02.12 AM IST
- Ranbaxy to pick stake in Jupiter Bio
The firm said it would seek the approval for the proposal from its Board of Directors on April 12.
06 Apr, 2007, 05.58 PM IST
- Ranbaxy to pick up stake in Jupiter
Jupiter Bioscience on Thrusday said that it plans to allot preferential equity share warrants to Ranbaxy.
06 Apr, 2007, 05.10 PM IST